Phytoglycogen improves the water solubility and Caco-2 monolayer permeation of quercetin

Food Chemistry

Volumn 221, Issue , 2017, Pages 248-257

  Chen, Hua ^a   Yao, Yuan ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Caco 2 permeation; Phytoglycogen; Quercetin; Water solubility

Indexed keywords

FLAVONOIDS; HYDROGEN BONDS; MONOLAYERS; PHENOLS; SOLUTIONS; X RAY POWDER DIFFRACTION;

CRYSTALLINITIES; ETHANOL SOLUTIONS; INTERMOLECULAR HYDROGEN BONDING; PERMEATION TEST; PHYTOGLYCOGEN; QUERCETIN; WATER SOLUBILITIES; WATER-SOLUBLE INGREDIENTS;

SOLUBILITY;

ALCOHOL; GLYCOGEN; HYDROXYL GROUP; PHYTOGLYCOGEN; QUERCETIN; UNCLASSIFIED DRUG; WATER;

AQUEOUS SOLUTION; ARTICLE; CACO 2 CELL LINE; CONTROLLED STUDY; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; HUMAN CELL; HYDROGEN BOND; INFRARED SPECTROSCOPY; VACUUM; X RAY POWDER DIFFRACTION; ANALOGS AND DERIVATIVES; CACO-2 CELL LINE; CHEMISTRY; MAIZE; MEDICINAL CHEMISTRY; PERMEABILITY; SOLUBILITY; X RAY DIFFRACTION;

CACO-2 CELLS; CHEMISTRY, PHARMACEUTICAL; GLYCOGEN; HUMANS; PERMEABILITY; QUERCETIN; SOLUBILITY; WATER; X-RAY DIFFRACTION; ZEA MAYS;

EID: 84992413337     PISSN: 03088146     EISSN: 18737072     Source Type: Journal    
DOI: 10.1016/j.foodchem.2016.10.064     Document Type: Article

References (38)

1. Aditya, N., Macedo, A.S., Doktorovova, S., Souto, E.B., Kim, S., Chang, P.-S., et al. Development and evaluation of lipid nanocarriers for quercetin delivery: A comparative study of solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE). LWT-Food Science and Technology 59 (2014), 115–121.
2. Althans, D., Schrader, P., Enders, S., Solubilisation of quercetin: Comparison of hyperbranched polymer and hydrogel. Journal of Molecular Liquids 196 (2014), 86–93.
3. Araujo, J., Araujo, D., Micellar systems of poloxamer 407 and 403 for quercetin delivery. BMC Proceedings, 2014 BioMed Central Ltd.
4. Boyer, J., Brown, D., Liu, R.H., In vitro digestion and lactase treatment influence uptake of quercetin and quercetin glucoside by the Caco-2 cell monolayer. Nutrition Journal 4 (2005), 1–15.
5. Chabane, M.N., Ahmad, A.A., Peluso, J., Muller, C.D., Ubeaud-Séquier, G., Quercetin and naringenin transport across human intestinal Caco-2 cells. Journal of Pharmacy and Pharmacology 61 (2009), 1473–1483.
6. Chen, H., Narsimhan, G., Yao, Y., Particulate structure of phytoglycogen studied using β-amylolysis. Carbohydrate Polymers 132 (2015), 582–588.
7. Dalvi, S.V., Dave, R.N., Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation. Industrial & Engineering Chemistry Research 48 (2009), 7581–7593.
8. Date, A.A., Nagarsenker, M.S., Patere, S., Dhawan, V., Gude, R., Hassan, P., et al. Lecithin-based novel cationic nanocarriers (leciplex) II: Improving therapeutic efficacy of quercetin on oral administration. Molecular Pharmaceutics 8 (2011), 716–726.
9. Dora, C.L., Silva, L.F., Putaux, J.-L., Nishiyama, Y., Pignot-Paintrand, I., Borsali, R., et al. Poly (ethylene glycol) hydroxystearate-based nanosized emulsions: Effect of surfactant concentration on their formation and ability to solubilize quercetin. Journal of Biomedical Nanotechnology 8 (2012), 202–210.
10. Freitas, S., Hielscher, G., Merkle, H.P., Gander, B., Continuous contact-and contamination-free ultrasonic emulsification—A useful tool for pharmaceutical development and production. Ultrasonics Sonochemistry 13 (2006), 76–85.
11. Ghows, N., Entezari, M.H., Fast and easy synthesis of core–shell nanocrystal (CdS/TiO2) at low temperature by micro-emulsion under ultrasound. Ultrasonics Sonochemistry 18 (2011), 629–634.
12. Gormaz, J., Quintremil, S., Rodrigo, R., Cardiovascular disease: A target for the pharmacological effects of quercetin. Current Topics in Medicinal Chemistry 15 (2015), 1735–1742.
13. Guo, Y., Bruno, R.S., Endogenous and exogenous mediators of quercetin bioavailability. The Journal of Nutritional Biochemistry 26 (2015), 201–210.
14. Hecq, J., Deleers, M., Fanara, D., Vranckx, H., Amighi, K., Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. International Journal of Pharmaceutics 299 (2005), 167–177.
15. Huang, L., Yao, Y., Particulate structure of phytoglycogen nanoparticles probed using amyloglucosidase. Carbohydrate Polymers 83 (2011), 1665–1671.
16. Kakran, M., Sahoo, N., Li, L., Dissolution enhancement of quercetin through nanofabrication, complexation, and solid dispersion. Colloids and Surfaces B: Biointerfaces 88 (2011), 121–130.
17. Khaled, K.A., El-Sayed, Y.M., Al-Hadiya, B.M., Disposition of the flavonoid quercetin in rats after single intravenous and oral doses. Drug Development and Industrial Pharmacy 29 (2003), 397–403.
18. Kim, K., Vance, T.M., Chun, O.K., Estimated intake and major food sources of flavonoids among US adults: Changes between 1999–2002 and 2007–2010 in NHANES. European Journal of Nutrition, 2015, 1–11.
19. Koontz, J.L., Marcy, J.E., O'Keefe, S.F., Duncan, S.E., Cyclodextrin inclusion complex formation and solid-state characterization of the natural antioxidants α-tocopherol and quercetin. Journal of Agricultural and Food Chemistry 57 (2009), 1162–1171.
20. Kumari, A., Yadav, S.K., Pakade, Y.B., Singh, B., Yadav, S.C., Development of biodegradable nanoparticles for delivery of quercetin. Colloids and Surfaces B: Biointerfaces 80 (2010), 184–192.
21. Li, B., Konecke, S., Harich, K., Wegiel, L., Taylor, L.S., Edgar, K.J., Solid dispersion of quercetin in cellulose derivative matrices influences both solubility and stability. Carbohydrate Polymers 92 (2013), 2033–2040.
22. Mukai, R., Fujikura, Y., Murota, K., Uehara, M., Minekawa, S., Matsui, N., et al. Prenylation enhances quercetin uptake and reduces efflux in Caco-2 cells and enhances tissue accumulation in mice fed long-term. The Journal of Nutrition 143 (2013), 1558–1564.
23. Mullen, W., Edwards, C.A., Crozier, A., Absorption, excretion and metabolite profiling of methyl-, glucuronyl-, glucosyl- and sulpho-conjugates of quercetin in human plasma and urine after ingestion of onions. British Journal of Nutrition 96 (2006), 107–116.
24. Murota, K., Shimizu, S., Chujo, H., Moon, J.-H., Terao, J., Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Archives of Biochemistry and Biophysics 384 (2000), 391–397.
25. Pool, H., Mendoza, S., Xiao, H., McClements, D.J., Encapsulation and release of hydrophobic bioactive components in nanoemulsion-based delivery systems: Impact of physical form on quercetin bioaccessibility. Food & Function 4 (2013), 162–174.
26. Ratnam, D.V., Ankola, D.D., Bhardwaj, V., Sahana, D.K., Kumar, M.N.V.R., Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. Journal of Controlled Release 113 (2006), 189–207.
27. Rezaei-Sadabady, R., Eidi, A., Zarghami, N., Barzegar, A., Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes. Artificial Cells, Nanomedicine, and Biotechnology, 2014, 1–7.
28. Sampson, L., Rimm, E., Hollman, P.C., de VRIES, J.H., Katan, M.B., Flavonol and flavone intakes in US health professionals. Journal of the American Dietetic Association 102 (2002), 1414–1420.
29. Scarfato, P., Avallone, E., Iannelli, P., Aquino, R.P., Lauro, M.R., Rossi, A., et al. Quercetin microspheres by solvent evaporation: Preparation, characterization and release behavior. Journal of Applied Polymer Science 109 (2008), 2994–3001.
30. Spencer, J., Kuhnle, G., Williams, R., Rice-Evans, C., Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochemical Journal 372 (2003), 173–181.
31. Sun, M., Wang, S., Nie, S., Zhang, J., Enhanced oral bioavailability of quercetin by nanostructured lipid carriers. The FASEB Journal, 28, 2014 1044.24.
32. Tian, X.-J., Yang, X.-W., Yang, X., Wang, K., Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model. International Journal of Pharmaceutics 367 (2009), 58–64.
33. Tran, T.H., Guo, Y., Song, D., Bruno, R.S., Lu, X., Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability. Journal of Pharmaceutical Sciences 103 (2014), 840–852.
34. Walgren, R.A., Lin, J.T., Kinne, R.K.H., Walle, T., Cellular uptake of dietary flavonoid quercetin 4′-β-glucoside by sodium-dependent glucose transporter SGLT1. Journal of Pharmacology and Experimental Therapeutics 294 (2000), 837–843.
35. Walgren, R.A., Walle, U.K., Walle, T., Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochemical Pharmacology 55 (1998), 1721–1727.
36. Wu, T.H., Yen, F.L., Lin, L.T., Tsai, T.R., Lin, C.C., Cham, T.M., Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles. International Journal of Pharmaceutics 346 (2008), 160–168.
37. Zhang, L., Yang, X., Li, S., Gao, W., Preparation, physicochemical characterization and in vitro digestibility on solid complex of maize starches with quercetin. LWT-Food Science and Technology 44 (2011), 787–792.
38. Zhang, Y., Yang, Y., Tang, K., Hu, X., Zou, G., Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles. Journal of Applied Polymer Science 107 (2008), 891–897.